Living Cell Technologies Limited
OTC: LVCLY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- David Richard Hainsworth
- Employees
- 48
- Headquarters
- Sydney, Australia
- IPO year
- 2008
- Market cap
- $11.4M
- Website
- https://www.lctglobal.com
Loading LVCLY…
Loading profile data…Frequently asked questions about LVCLY
What does Living Cell Technologies Limited (LVCLY) do?
Living Cell Technologies Limited (LCT) is a biotechnology company dedicated to the innovation, development, and market introduction of regenerative medical therapies. These treatments leverage naturally occurring cells with the aim of restoring physiological functions, particularly within New Zealand. A primary focus for LCT is NTCELL, a novel a...
Where does LVCLY trade?
Living Cell Technologies Limited (LVCLY) trades on the Other OTC.
What sector is LVCLY in?
Living Cell Technologies Limited (LVCLY) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Living Cell Technologies Limited?
David Richard Hainsworth is the chief executive officer of Living Cell Technologies Limited (LVCLY).
Where is Living Cell Technologies Limited headquartered?
Living Cell Technologies Limited is headquartered in Australia.
Does LVCLY pay a dividend?
Living Cell Technologies Limited (LVCLY) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LVCLY go public?
Living Cell Technologies Limited (LVCLY) completed its initial public offering in 2008.
Is LVCLY an ADR?
Yes — LVCLY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Living Cell Technologies Limited reporting and dividends follow the underlying issuer.